Balicatib treatment of PTM cells produced no significant changes in pro- and active-CTSB levels compared with the DMSO control. Western blotting revealed an inhibitory effect of Balicatib on CTSK protein levels in Huh7 and HepG2 cells. In Caki cells, Balicatib induced down-regulation of c-FLIP and Mcl-1 expression and up-regulation of Bim and Bax expression. In freshly enucleated porcine eyes, Balicatib perfusion was followed by a significant increase in IOP. [1,2,3]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
CTSB Protein Expression in PTM Cells
Cell-based study · PTM cells [1]
PTM cells treated with Balicatib at 10 µM for 24 h showed no significant changes in pro- and active-CTSB levels compared with the DMSO control.
Literature-Reported Treatment Conditions
- Treatment concentration
- 10 µM
- Exposure duration
- for 24 h
- Vehicle
- DMSO
- Reported limits
- Not stated in the sentences used: route.
Methods and source locations
Compound reported in the paper: Balicatib
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
3. Results > 3.2. Pharmacological Inhibition of CTSK Elevates IOP by Increasing the COL1A Deposition in TM (S146, S147)
protein expression of CTSB: protein expression of CTSB; comparator: DMSO control — 3. Results > 3.2. Pharmacological Inhibition of CTSK Elevates IOP by Increasing the COL1A Deposition in TM (S146, S147)
CTSK Protein Levels in Huh7 and HepG2 Cells
Cell-based study · Huh7 [2]
Western blotting revealed an inhibitory effect of Balicatib on CTSK protein levels in Huh7 and HepG2 cells.
Literature-Reported Treatment Conditions
- Reported limits
- Not stated in the sentences used: dose, route, schedule, vehicle, control.
Methods and source locations
Compound reported in the paper: Balicatib
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Figure 3 legend (S143)
CTSK protein levels: CTSK protein levels — Figure 3 legend (S143)
Protein Expression Changes in Caki Cells
Cell-based study · Caki cells [3]
Caki cells treated with various concentrations of Balicatib for 24 h showed down-regulation of c-FLIP and Mcl-1 expression and up-regulation of Bim and Bax expression.
Literature-Reported Treatment Conditions
- Exposure duration
- 24 h
- Reported limits
- Not stated in the sentences used: dose, route, vehicle.
Methods and source locations
Compound reported in the paper: Balicatib
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Up-regulation of Bim expression plays a critical role in the enhancement of the cytotoxicity of anti-cancer drugs (S75); Fig. 3 legend (S150, S154, S155)
protein expression: protein expression; comparator: the control — Results > Up-regulation of Bim expression plays a critical role in the enhancement of the cytotoxicity of anti-cancer drugs (S75); Fig. 3 legend (S150, S154)
IOP Following Perfusion in Porcine Eyes
Cell-based study · freshly enucleated porcine eyes [1]
Freshly enucleated porcine eyes perfused with Balicatib at 10 μM showed a significant increase in IOP following perfusion.
Literature-Reported Treatment Conditions
- Treatment concentration
- 10 μM
- Exposure duration
- for 24 h after the establishment of a baseline for up to 20 h
- Method
- perfused
- Vehicle
- DMSO
Methods and source locations
Compound reported in the paper: Balicatib
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
3. Results > 3.2. Pharmacological Inhibition of CTSK Elevates IOP by Increasing the COL1A Deposition in TM (S152, S153, S154); Figure 3 legend (S272, S273)
IOP readings: IOP readings; comparator: vehicle DMSO perfused control — 3. Results > 3.2. Pharmacological Inhibition of CTSK Elevates IOP by Increasing the COL1A Deposition in TM (S153, S154)